Remove 2014 Remove Dementia Remove Outcomes
article thumbnail

Do Amyloid Cerebral Deposits Influence the Long-Term Poststroke Cognitive Outcome?: The IDEA3 Study

Stroke Journal

BACKGROUND:Although the presence of amyloid deposits is associated with a more severe cognitive status in patients with stroke at baseline, its influence on the subsequent cognitive outcome has not been extensively assessed. Patients underwent annually comprehensive clinical and cognitive assessments for 5 years after the PET scan.

article thumbnail

Why Exercise Is The Key To A Longer Life

Dr. Paddy Barrett

While I have covered many of these fitness measures individually in previous posts, I wanted to summarise these metrics and how they relate to living longer and preventing major diseases such as cardiovascular disease, cancer and dementia. Fitness & Dementia This relationship is also clearly evident when it comes to rates of dementia.

Exercise 113
article thumbnail

ACC/AHA Release Updated 2023 Guidelines for Atrial Fibrillation

Cardiometabolic Health Congress

These new guidelines provide necessary updates to both the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation and the 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation. million.

article thumbnail

Abstract 4141439: Catheter ablation and clinical outcomes among older Medicare beneficiaries with atrial fibrillation

Circulation

The aim of this study is to examine the risks of adverse outcomes following CA in older people with AF.Methods:Using 2014-2019 Medicare claims, we conducted a propensity score analysis of patients treated with CA within 6 months of new AF diagnosis to patients treated with only antiarrhythmic therapy in the 6-month period.

article thumbnail

The legal case – naming a few names

Dr. Malcolm Kendrick

plus drug supply BEST-D pilot trial of vitamin D (2012-2014) Tishcon: free drug supply only Big Data Institute (2018-2021) Novartis Pharma AG Switzerland: £272K Can wearables improve the prediction of all-cause mortality, cardiovascular disease, and cancer in UK Biobank? plus drug supply Bayer: £1.8M